|
Flanders Interuniversity Institute Of Biotechnology
VIB is a research institute located in Flanders, Belgium. It was founded by the Flemish government in 1995, and became a full-fledged institute on 1 January 1996. The main objective of VIB is to strengthen the excellence of Flemish life sciences research and to turn the results into new economic growth. VIB spends almost 80% of its budget on research activities, while almost 12% is spent on technology transfer activities and stimulating the creation of new businesses, in addition VIB spends approximately 2% on socio-economic activities. VIB is member of EU-LIFE, an alliance of leading life sciences research centres in Europe. The institute is led by Christine Durinx and Jérôme Van Biervliet. Ajit Shetty is chairman of the board of directors. Goals VIB's mission is ''to conduct frontline biomolecular research in life sciences for the benefit of scientific progress and the benefit of society''. The strategic goals of the VIB are: # Strategic basic research # Technology transfer po ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Flanders, Belgium
Flanders (, ; Dutch: ''Vlaanderen'' ) is the Flemish-speaking northern portion of Belgium and one of the communities, regions and language areas of Belgium. However, there are several overlapping definitions, including ones related to culture, language, politics, and history, and sometimes involving neighbouring countries. The demonym associated with Flanders is Fleming, while the corresponding adjective is Flemish. The official capital of Flanders is the City of Brussels, although the Brussels-Capital Region that includes it has an independent regional government. The powers of the government of Flanders consist, among others, of economic affairs in the Flemish Region and the community aspects of Flanders life in Brussels, such as Flemish culture and education. Geographically, Flanders is mainly flat, and has a small section of coast on the North Sea. It borders the French department of Nord to the south-west near the coast, the Dutch provinces of Zeeland, North Brabant a ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
KU Leuven
KU Leuven (or Katholieke Universiteit Leuven) is a Catholic research university in the city of Leuven, Belgium. It conducts teaching, research, and services in computer science, engineering, natural sciences, theology, humanities, medicine, law, canon law, business, and social sciences. In addition to its main campus in Leuven, it has satellite campuses in Kortrijk, Antwerp, Ghent, Bruges, Ostend, Geel, Diepenbeek, Aalst, Sint-Katelijne-Waver, and in Belgium's capital Brussels. KU Leuven is the largest university in Belgium and the Low Countries. In 2017–18, more than 58,000 students were enrolled. Its primary language of instruction is Dutch, although several programs are taught in English, particularly graduate and postgraduate degrees. KU Leuven consistently ranks among the top 100 universities in the world by major ranking tables. As of 2021, it ranks 42nd in the ''Times Higher Education'' rankings, 70th according QS World University Rankings, 87th according to the Sh ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
EMBL
The European Molecular Biology Laboratory (EMBL) is an intergovernmental organization dedicated to molecular biology research and is supported by 27 member states, two prospect states, and one associate member state. EMBL was created in 1974 and is funded by public research money from its member states. Research at EMBL is conducted by approximately 110 independent research and service groups and teams covering the spectrum of molecular biology and bioinformatics. The list of Groups and Teams at EMBL can be found at . The Laboratory operates from six sites: the main laboratory in Heidelberg, and sites in Hinxton (the European Bioinformatics Institute (EBI), in England), Grenoble (France), Hamburg (Germany), Rome (Italy) and Barcelona (Spain). EMBL groups and laboratories perform basic research in molecular biology and molecular medicine as well as train scientists, students, and visitors. The organization aids in the development of services, new instruments and methods, and techno ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Hasselt University
Hasselt University (Dutch: ''Universiteit Hasselt or UHasselt'') is a public research university with campuses in Hasselt and Diepenbeek, Belgium. It has more than 6,700 students and 1,660 academic, administrative and technical staff (2022). The university was officially established in 1971 as the Limburg Universitair Centrum (LUC) and changed its name to Hasselt University in 2005. UHasselt is ranked 53rd out of 539 in the 2022 ''Times Higher Education'' ranking of universities younger than 50 years. In the European Commission's ''U-Multirank 2022'', UHasselt scores a top ten overall result, with fifteen excellent indicators. Hasselt University has an extensive regional, national and global network of more than 500 partners, fostering collaboration in education, research and innovation. As of October 2020, Rector of Hasselt University is Prof. Bernard Vanheusden. Vice-Rector for Education is Prof. Wanda Guedens, Vice-Rector for Research Prof. Ken Haenen. History Establishme ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
BIOMED
BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. It was founded in 2000 and has been owned by Springer, now Springer Nature, since 2008. History BioMed Central was founded in 2000 as part of the Current Science Group (now Science Navigation Group, SNG), a nursery of scientific publishing companies. SNG chairman Vitek Tracz developed the concept for the company after NIH director Harold Varmus's PubMed Central concept for open-access publishing was scaled back. The first director of the company was Jan Velterop. Chemistry Central was established in 2006 and the PhysMath Central journal imprint in 2007. In 2002, the company introduced article processing charges, and these have since been the primary source of revenue. In 2007 Yale University Libraries stopped s ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Belgian Society Of Biochemistry And Molecular Biology
The Belgian Society of Biochemistry and Molecular Biology (BMB) is a Belgian non-profit organization, concerned with biochemistry and molecular biology. The BMB was created, based on an initiative of Marcel Florkin, so a Belgian society could join the new International Union of Biochemistry. The first charter of the society was drafted by Edouard J. Bigwood, Jean Brachet, Christian de Duve, Marcel Florkin, Lucien Massart, Paul Putzeys, Laurent Vandendriessche and Claude Lièbecq. The first general assembly was held on 12 January 1952, and the first President of the society was Marcel Florkin, with Claude Lièbecq as secretary and treasurer. See also * BIO.be * National Fund for Scientific Research The National Fund for Scientific Research (NFSR) (Dutch: ''Nationaal Fonds voor Wetenschappelijk Onderzoek'' (NFWO), French: ''Fonds National de la Recherche Scientifique'' (FNRS)) was once a government institution in Belgium for supporting scien ... References External links B ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
ActoGeniX
''Lactococcus lactis'' is a Gram-positive bacterium used extensively in the production of buttermilk and cheese, but has also become famous as the first genetically modified organism to be used alive for the treatment of human disease. ''L. lactis'' cells are cocci that group in pairs and short chains, and, depending on growth conditions, appear ovoid with a typical length of 0.5 - 1.5 µm. ''L. lactis'' does not produce spores ( nonsporulating) and are not motile ( nonmotile). They have a homofermentative metabolism, meaning they produce lactic acid from sugars. They've also been reported to produce exclusive L-(+)-lactic acid. However, reported D-(−)-lactic acid can be produced when cultured at low pH. The capability to produce lactic acid is one of the reasons why ''L. lactis'' is one of the most important microorganisms in the dairy industry. Based on its history in food fermentation, ''L. lactis'' has generally recognized as safe (GRAS) status, with few case reports ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
CropDesign
CropDesign is a biotech company located in Ghent, Belgium. The company develops a portfolio of agronomic traits for the global commercial seed markets. It has developed a technology platform to discover genetic traits for the improvement of corn, rice and other plants. Current Managing Director is Juergen Logemann. History CropDesign was founded in 1998 as a spin-off from the Flanders Institute of Biotechnology (VIB) and the Institute of Plant Biotechnology for Developing Countries of the University of Ghent. One of the founders of the company is Marc Van Montagu who is a Flemish pioneer in plant genetics. Another co-founder was Professor Dirk Inzé, specialist in plant cell cycle technologies. The company was financially backed until 2006 by a consortium of venture capital funds led by the GIMV. BASF Plant Science acquired the company in 2006. The company announced in May 2016 that they would cease operations by the end of the year. BASF stated at the time that they wished ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
DevGen
Devgen is a Belgium-based multinational agricultural biotechnology company. It uses biotechnology and molecular breeding technologies to develop varieties of food crops. Its technology is marketed by outlicensing or selling seeds in India and South-East Asia. Devgen also develops nematicides. History RNA interference spin off Devgen was founded as a spin-off of Ghent University and The Flemish Institute for Biotechnology in 1997 to commercialize intellectual property it licensed on the use of RNAi in nematodes and its use for screening for therapeutics and/or their targets. Its work focused on the nematode ''C. elegans'' as a model system, which functions as a model for human diseases, but also as a model for the kind of nematodes that are agricultural pests. The company raised 37 million Euro in its first three years, first from the GIMV and Abingworth investment companies at its launch, then from the IWT, then from another round of private investors including ING, KBC, L ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Ablynx
Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent. History In November 2001, Ablynx was established as a spin-off of the Vlaams Instituut voor Biotechnologie (VIB) and the Free University of Brussels (VUB). Seed financing of was provided by Gimv. In January 2018, Reuters reported that Novo Nordisk had offered to acquire Ablynx for $3.1 billion — having made an unreported offer in mid-December for the company. However, the Ablynx board rejected this offer the same day, saying that the price undervalued the business. In January 2018, they were acquired by Sanofi Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Syn ... for $4.8 Billion. The acquisition was led by Chief Broker Gle ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Nanobody
A single-domain antibody (sdAb), also known as a nanobody, is an antibody fragment consisting of a single monomeric Variable region, variable antibody domain. Like a whole antibody, it is able to bind selectively to a specific antigen. With a molecular weight of only 12–15 kDa, single-domain antibodies are much smaller than common antibodies (150–160 kDa) which are composed of two Immunoglobulin heavy chain, heavy protein chains and two Immunoglobulin light chain, light chains, and even smaller than Fab fragments (~50 kDa, one light chain and half a heavy chain) and single-chain variable fragments (~25 kDa, two variable domains, one from a light and one from a heavy chain). The first single-domain antibodies were engineered from heavy-chain antibodies found in camelids; these are called VHH fragments. Cartilaginous fishes also have heavy-chain antibodies (IgNAR, 'immunoglobulin new antigen receptor'), from which single-domain antibodies called VNAR fragments can be obtained. A ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
.png "Click for more on -> Nanobody")